188260 — Sanigen Co Balance Sheet
0.000.00%
- KR₩19bn
- KR₩17bn
- KR₩24bn
Annual balance sheet for Sanigen Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | — | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 637 | 9,770 | 3,527 | 12,113 | 5,530 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,583 | 3,707 | 4,301 | 2,690 | 4,536 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6,338 | 15,388 | 10,007 | 16,780 | 11,852 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1,653 | 1,586 | 5,153 | 4,531 | 4,520 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 8,285 | 17,345 | 15,635 | 21,448 | 16,642 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12,906 | 24,392 | 25,191 | 2,648 | 2,407 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 14,914 | 26,511 | 28,559 | 7,581 | 6,446 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | -6,629 | -9,166 | -12,924 | 13,867 | 10,196 |
Total Liabilities & Shareholders' Equity | 8,285 | 17,345 | 15,635 | 21,448 | 16,642 |
Total Common Shares Outstanding |